XML 33 R7.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - BRL (R$)
R$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
OPERATING ACTIVITIES      
Net income (loss) for the year R$ (10,714,935) R$ (2,814,742) R$ 319,814
Adjustment to      
Depreciation, depletion and amortization (Notes 27 and 30) [1] 6,565,441 7,898,775 1,563,223
Amortization of right of use (Note 19.1) 186,768 154,217  
Sublease of ships (35,841)    
Interest expense on lease liabilities 397,746 226,103  
Results from sale, disposals and provision for losses (impairment) of property, plant and equipment and biological assets, net (Note 30) (53,807) 77,930 13,580
Income (loss) from associates and joint ventures (Note 14.2) (36,142) (31,993) (7,576)
Exchange rate and monetary variations, net (Note 27) 12,530,891 1,964,927 1,446,207
Interest expenses with financing, loans and debentures, net (Note 27) 3,286,254 3,363,019 872,208
Premium expenses with repurchase of bonds (Note 27) 391,390    
Capitalized interest (Note 27) (10,636) (4,213)  
Accrual of interest on marketable securities (94,868) (392,018) (127,037)
Amortization of fundraising costs (Notes 27) 101,741 185,807 44,499
Derivative (gains) losses, net (Note 27) 9,422,682 1,075,252 2,735,196
Fair value adjustment of biological assets (Note 13) (466,484) (185,399) 129,187
Deferred income tax and social contribution expenses (Note 12.3) (7,109,120) (1,528,571) (741,084)
Tax credits - gains in tax lawsuit (ICMS from the PIS/COFINS calculation basis) (note 9)   (128,115)  
Interest on employee benefits (Note 21.2) 53,092 44,496 35,920
Provision for (reversal of) judicial liabilities, net (Note 20.1) 1,288 26,807 13,285
Allowance for doubtful accounts, net (Note 7.3) 6,022 (12,286) 6,450
Provision for (reversal of) inventory losses, net (Note 8.1) 65,675 107,269 (25,096)
Provision for loss of ICMS credits, net (Note 9.1) (82,293) 129,283  
Impairment of non-financial assets (Note 16.1) 45,435    
Other 35,451 (56,517) 235,081
Decrease (increase) in assets      
Trade accounts receivables 884,451 991,476 (186,026)
Inventories 651,203 873,420 (622,151)
Recoverable taxes 659,930 241,934 50,960
Other assets 54,651 (26,478) (12,720)
Increase (decrease) in liabilities      
Trade accounts payables 140,480 (1,555,697) 1,473
Taxes payable 47,212 240,871 432,603
Payroll and charges 92,278 (234,948) (100,124)
Other liabilities (266,546) (62,294) 225,616
Cash provided by operations, net 16,749,409 10,568,315 6,303,488
Payment of interest with financing, loans and debentures (Note 18.2) (3,244,949) (2,977,957) (806,758)
Payment of premium with repurchase of bonds (Note 18.2) (378,381)    
Interest received from marketable securities 186,853 377,804  
Payment of income taxes (188,296) (391,725) (327,282)
Cash provided by operating activities 13,124,636 7,576,437 5,169,448
INVESTING ACTIVITIES      
Additions to property, plant and equipment (Note 15) (1,503,255) (2,001,674) (1,251,486)
Additions to intangible assets (Note 16) (2,307) (17,715) (7,217)
Additions to biological assets (Note 13) (3,392,298) (2,849,038) (1,164,995)
Proceeds from sale of property, plant and equipment 183,504 198,644 95,481
Increase of capital in subsidiaries and associates (Note 14.3)   (45,856)  
Marketable securities, net 3,841,493 19,378,893 (19,340,022)
Advance for acquisition of wood from operations with development 135,693 (355,447) 1,402
Acquisition of subsidiaries, net cash   (26,002,540) (294,473)
Dividends received 753    
Other investments   (286)  
Cash (used) in investing activities, net (736,417) (11,695,019) (21,961,310)
FINANCING ACTIVITIES      
Proceeds from loans, financing and debentures (Note 18.2) 14,761,796 18,993,837 25,645,822
Payment of derivative transactions (note 4.5.4) (4,465,640) (135,449) (1,586,415)
Payment of loans, financing and debentures (note 18.2) (19,092,810) (13,994,708) (3,738,577)
Payment of leases (note 19.2) (824,245) (645,071)  
Payment of dividends   (606,632) (210,205)
Sale of treasury shares to meet stock-based compensation plan   (879) 8,514
Liabilities for assets acquisitions and subsidiaries (164,240) (479,480) (84,090)
Other financing   10,191  
Cash provided (used) by financing activities (9,785,139) 3,141,809 20,035,049
EXCHANGE VARIATION ON CASH AND CASH EQUIVALENTS 982,850 (161,553) 67,433
Increase (reduction) in cash and cash equivalents, net 3,585,930 (1,138,326) 3,310,620
Cash and cash equivalents at the beginning for the year 3,249,127 4,387,453 1,076,833
Cash and cash equivalents at the end for the year 6,835,057 3,249,127 4,387,453
Increase (reduction) in cash and cash equivalents, net R$ 3,585,930 R$ (1,138,326) R$ 3,310,620
[1] In the year ended December 31, 2019 includes the full amortization of the inventories step up, resulting from the business combination with Fibria, in the amount of R$2,178,903.